GlobeNewsWire
06 Jun 2026, 21:00 UTC · 15w ago
Verdict
Headline leans bullish. We score SENS +1.00 across three claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+1.00strongly bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Real-world data for the Eversense 365 CGM shows consistent accuracy and performance across a full one-year period from a single sensor.
More positive than 92% of claims this week
The Eversense 365 demonstrated strong clinical performance and glucometrics when integrated into the twiist Automated Insulin Delivery (AID) closed-loop system.
Continue reading
5 related stories
More positive than 98% of ticker scores this week
Scored by the NIS engine · methodology.
Search tags
More positive than 85% of claims this week
A large-scale study of 12,360 sensors showed a high average transmitter wear time of 93.19% across all age groups.
More positive than 76% of claims this week
Which stocks this story touches
More positive than 98% of ticker scores this week
The company presented strong real-world evidence data showing high accuracy, performance, and patient impact for its Eversense 365 CGM system.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
3d ago
+43.6%
Price agrees with the score
$9.58 vs $6.67 close before publication (Jun 5) · not market-adjusted
SENS chart →
